How race and ethnicity affect treatment outcomes in breast cancer patients using specific inhibitors
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors
This study is looking at how well a new treatment works for hormone receptor-positive breast cancer in African American women compared to European American women, and it wants to understand how genetics, sticking to treatment, and social factors might affect their outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10932935 on NIH RePORTER |
What this research studies
This research investigates the differences in treatment outcomes for hormone receptor-positive breast cancer patients, particularly focusing on African American women compared to European American women. It examines the effectiveness of CDK4/6 inhibitors, a new treatment strategy, and explores the roles of genetic factors, medication adherence, and social determinants of health in these outcomes. By analyzing data from various databases, including The Cancer Genomic Atlas, the study aims to uncover the reasons behind the disparities in survival rates among different racial and ethnic groups.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with hormone receptor-positive breast cancer, particularly those who are African American.
Not a fit: Patients with other subtypes of breast cancer or those who do not identify as African American may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and outcomes for African American women with breast cancer.
How similar studies have performed: Previous studies have shown disparities in treatment outcomes based on race and ethnicity, indicating that this research is building on established findings rather than exploring a completely novel approach.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Kaipparettu, Benny Abraham — Baylor College of Medicine
- Study coordinator: Kaipparettu, Benny Abraham
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.